These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

450 related articles for article (PubMed ID: 26809712)

  • 21. Dissociation of infectivity from seeding ability in prions with alternate docking mechanism.
    Miller MB; Geoghegan JC; Supattapone S
    PLoS Pathog; 2011 Jul; 7(7):e1002128. PubMed ID: 21779169
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Residue-specific mobility changes in soluble oligomers of the prion protein define regions involved in aggregation.
    Glaves JP; Ladner-Keay CL; Bjorndahl TC; Wishart DS; Sykes BD
    Biochim Biophys Acta Proteins Proteom; 2018 Sep; 1866(9):982-988. PubMed ID: 29935976
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Formation of soluble oligomers and amyloid fibrils with physical properties of the scrapie isoform of the prion protein from the C-terminal domain of recombinant murine prion protein mPrP-(121-231).
    Martins SM; Frosoni DJ; Martinez AM; De Felice FG; Ferreira ST
    J Biol Chem; 2006 Sep; 281(36):26121-8. PubMed ID: 16844683
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Mechanisms of prion transmission].
    Sakaguchi S
    Nihon Rinsho; 2007 Aug; 65(8):1391-5. PubMed ID: 17695274
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of GPI-anchored PrP C in mediating the neurotoxic effect of scrapie prions in neurons.
    Radford HE; Mallucci GR
    Curr Issues Mol Biol; 2010; 12(2):119-27. PubMed ID: 19767655
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characterisation of new monoclonal antibodies reacting with prions from both human and animal brain tissues.
    Cordes H; Bergström AL; Ohm J; Laursen H; Heegaard PM
    J Immunol Methods; 2008 Sep; 337(2):106-20. PubMed ID: 18657541
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Modulation of proteinase K-resistant prion protein in cells and infectious brain homogenate by redox iron: implications for prion replication and disease pathogenesis.
    Basu S; Mohan ML; Luo X; Kundu B; Kong Q; Singh N
    Mol Biol Cell; 2007 Sep; 18(9):3302-12. PubMed ID: 17567949
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Protease-sensitive synthetic prions.
    Colby DW; Wain R; Baskakov IV; Legname G; Palmer CG; Nguyen HO; Lemus A; Cohen FE; DeArmond SJ; Prusiner SB
    PLoS Pathog; 2010 Jan; 6(1):e1000736. PubMed ID: 20107515
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ubiquitin-specific protease 14 modulates degradation of cellular prion protein.
    Homma T; Ishibashi D; Nakagaki T; Fuse T; Mori T; Satoh K; Atarashi R; Nishida N
    Sci Rep; 2015 Jun; 5():11028. PubMed ID: 26061634
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Novel amplification mechanism of prions through disrupting sortilin-mediated trafficking.
    Sakaguchi S; Uchiyama K
    Prion; 2017 Nov; 11(6):398-404. PubMed ID: 29099278
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A new method for the characterization of strain-specific conformational stability of protease-sensitive and protease-resistant PrPSc.
    Pirisinu L; Di Bari M; Marcon S; Vaccari G; D'Agostino C; Fazzi P; Esposito E; Galeno R; Langeveld J; Agrimi U; Nonno R
    PLoS One; 2010 Sep; 5(9):e12723. PubMed ID: 20856860
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Utility of RNAi-mediated prnp gene silencing in neuroblastoma cells permanently infected by prions: potentials and limitations.
    Kim Y; Han B; Titlow W; Mays CE; Kwon M; Ryou C
    Antiviral Res; 2009 Nov; 84(2):185-93. PubMed ID: 19748523
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Establishment of a prion disease PrP(Sc) panel from the brain tissues of experimental hamsters infected with scrapie agent 263K].
    Zhang BY; Tian C; Han J; Gao C; Shi Q; Jiang HY; Zhou W; Dong XP
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2008 Oct; 22(5):321-3. PubMed ID: 19469162
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Discriminating between cellular and misfolded prion protein by using affinity to 9-aminoacridine compounds.
    Phuan PW; Zorn JA; Safar J; Giles K; Prusiner SB; Cohen FE; May BCH
    J Gen Virol; 2007 Apr; 88(Pt 4):1392-1401. PubMed ID: 17374787
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chicken antibody against a restrictive epitope of prion protein distinguishes normal and abnormal prion proteins.
    Miyamoto K; Kimura S; Nakamura N; Yokoyama T; Horiuchi H; Furusawa S; Matsuda H
    Biologicals; 2007 Oct; 35(4):303-8. PubMed ID: 17363268
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intermolecular crosslinking of abnormal prion protein is efficiently induced by a primuline-sensitized photoreaction.
    Teruya K; Nishizawa K; Oguma A; Sakasegawa Y; Kitamoto T; Doh-Ura K
    Biochim Biophys Acta Gen Subj; 2019 Feb; 1863(2):384-394. PubMed ID: 30447252
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The N-Terminal Polybasic Region of Prion Protein Is Crucial in Prion Pathogenesis Independently of the Octapeptide Repeat Region.
    Das NR; Miyata H; Hara H; Chida J; Uchiyama K; Masujin K; Watanabe H; Kondoh G; Sakaguchi S
    Mol Neurobiol; 2020 Feb; 57(2):1203-1216. PubMed ID: 31707632
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The first non-prion pathogen identified: neurotropic influenza virus.
    Sakaguchi S; Hara H
    Prion; 2022 Dec; 16(1):1-6. PubMed ID: 34978525
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Putting prions into focus: application of single molecule detection to the diagnosis of prion diseases.
    Giese A; Bieschke J; Eigen M; Kretzschmar HA
    Arch Virol Suppl; 2000; (16):161-71. PubMed ID: 11214919
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prion infection of mouse neurospheres.
    Giri RK; Young R; Pitstick R; DeArmond SJ; Prusiner SB; Carlson GA
    Proc Natl Acad Sci U S A; 2006 Mar; 103(10):3875-80. PubMed ID: 16495413
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.